Altmetric
1500TiP REFINE-Lung is a multicentre phase III study to determine the optimal frequency of pembrolizumab in non-small cell lung cancer utilising a novel multi-arm design
| File | Description | Size | Format | |
|---|---|---|---|---|
 REFINE-Lung TIP_ESMO 2023_final.docx | Submitted version | 18.05 kB | Microsoft Word | View/Open |
| Title: | 1500TiP REFINE-Lung is a multicentre phase III study to determine the optimal frequency of pembrolizumab in non-small cell lung cancer utilising a novel multi-arm design |
| Authors: | Ghorani, E Quartagno, M Blackhall, F Gilbert, DC O'Brien, MER Ottensmeier, CHH Pizzo, E Spicer, J Williams, A Badman, P Milner-Watts, C Parmar, MK Seckl, MJ |
| Item Type: | Conference Paper |
| Issue Date: | 1-Oct-2023 |
| Date of Acceptance: | 1-Oct-2023 |
| URI: | http://hdl.handle.net/10044/1/113103 |
| DOI: | 10.1016/j.annonc.2023.09.2531 |
| ISSN: | 0923-7534 |
| Publisher: | Elsevier |
| Start Page: | S845 |
| End Page: | S845 |
| Journal / Book Title: | Annals of Oncology |
| Volume: | 34 |
| Copyright Statement: | © 2023 European Society for Medical Oncology. Published by Elsevier Inc. All rights reserved. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| Conference Name: | Annual Meeting of the European-Society-for-Medical-Oncology (ESMO) |
| Publication Status: | Published |
| Start Date: | 2023-10-20 |
| Finish Date: | 2023-10-24 |
| Conference Place: | Barcelona, Spain |
| Appears in Collections: | Department of Surgery and Cancer |
This item is licensed under a Creative Commons License
